[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on
|
|
- CAS-Nr.
- 3736-77-4
- Bezeichnung:
- [2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on
- Englisch Name:
- 2,2'-Cyclouridine
- Synonyma:
- Anhydro-U;2,2'-Anhydro-U;2'-Cyclouridine;2,2'-Anhydro-rU;02,2-Cycloridine;2, 2'-Anhydro-Ur;2,2'-Cyclouridine;O2,2'-cyclouridine;2,2'-O-Cyclouridine;Uridine Impurity 18
- CBNumber:
- CB2290216
- Summenformel:
- C9H10N2O5
- Molgewicht:
- 226.19
- MOL-Datei:
- 3736-77-4.mol
|
[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on Eigenschaften
- Schmelzpunkt:
- 248-251 °C(lit.)
- alpha
- -21°(19℃, c=4, H2O)
- Siedepunkt:
- 456.3±55.0 °C(Predicted)
- Dichte
- 2.01±0.1 g/cm3(Predicted)
- Brechungsindex
- -20 ° (C=4, H2O)
- storage temp.
- -20°C
- Löslichkeit
- DMSO:2.0(Max Conc. mg/mL);8.84(Max Conc. mM)
PBS (pH:7.2):1.0(Max Conc. mg/mL);4.42(Max Conc. mM)
- Aggregatzustand
- powder to crystal
- pka
- 12.55±0.40(Predicted)
- Farbe
- White to Almost white
- Optische Aktivität
- [α]19/D 21°, c = 4 in H2O
- InChI
- InChI=1S/C9H10N2O5/c12-3-4-6(14)7-8(15-4)11-2-1-5(13)10-9(11)16-7/h1-2,4,6-8,12,14H,3H2/t4-,6-,7+,8-/m1/s1
- InChIKey
- UUGITDASWNOAGG-CCXZUQQUSA-N
- SMILES
- C12O[C@@]3([H])[C@H](O)[C@@H](CO)O[C@@]3([H])N1C=CC(=O)N=2
- CAS Datenbank
- 3736-77-4
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
S-Sätze: |
24/25 |
|
|
WGK Germany |
3 |
|
|
HS Code |
29349990 |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
Sicherheit |
P264 |
Nach Gebrauch gründlich waschen. |
P264 |
Nach Gebrauch gründlich waschen. |
P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
P501 |
Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White powder
Verwenden
Research tool for antiviral and anticancer studies.1
[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 412)Lieferanten
3736-77-4([2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on)Verwandte Suche:
Doxifluridin
Uridine
Trifluridin
5-Fluor-2'-desoxyuridin
1-β-D-Arabinofuranosyl-(1H,3H)-pyrimidin-2,4-dion
(S)-(+)-1-Aminopropan-2-ol
4-Methoxybutan-1-ol
2-(2-Methoxyethoxy)ethanol
3-Ethoxypropan-1,2-diol
2-Isopropoxy-ethanol
3-Dimethylaminopropan-1,2-diol
3-Dimethylaminopropan-1-ol
uridine diphosphate glucose {= UDP-glucose}
URACIL
[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on
- 2,2'-ANHYDRO-1(BETA-D-ARABINOFURANOSYL)URACIL
- 2, 2'-ANHYDRO-1-(B-D-ARABINOFURANOSYL) URACIL
- 2,2'-Cyclouridine
- BETA-D-O(2),2'-CYCLOURIDINE
- 02,2-Cycloridine
- [2R-(2alpha,3beta,3abeta,9abeta)]-2,3,3a,9a-tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
- 2,2'-Anhydro-1(-D-arabinofuranosyl)uracil
- 3736-77-4 2,2'-Anhydrouridine 7410
- 2,2'-ANHYDRO-(1-B-D-ARABINOFURANOSYL)URA CIL FREE B
- 2,2'-Anhydro-1(beta-D-Arabinof
- 2,2'-Anhydro-D-uridine
- 2,2''-ANHYDRO-1(SS-D-ARABINOFURANOSYL)URACIL
- 2, 2''-ANHYDROURIDINE (2, 2''-O-CYCLOURIDINE)
- 2,2'-O-Anhydro-(1-beta-D-arabinofuranosyl)uracil
- 2,2'-O-Cyclouridine
- O(sup 2),2'-cyclouridine
- β-D-O2,2μ-Cyclouridine, O2,2μ-Cyclouridine
- (2R)-2,3,3aβ,9aβ-Tetrahydro-3β-hydroxy-2α-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
- (2R,3aβ,9aβ)-2,3,3a,9a-Tetrahydro-3β-hydroxy-2α-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
- (2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
- Anhydro-U
- 2,2'-Anhydro-U
- 2,2'-O-Anhydro-(1-beta-D-arabinofuranosyl)uracil
O2,2′-Cyclouridine
- 2,2'-Cyclouridine
2,2'-Anhydro-1-(beta-D-arabinofuranosyl) uracil
- β-D-O2,2′-Cyclouridine
- 2,2'-O-Anhydro-(1-β-D-arabinofuranosyl)uracil
- 2'-Cyclouridine
- Uridine Impurity 18
- 2,2'-Anhydrouridine (Synonyms: 2,2'-Cyclouridine
- 2,2'-Anhydrouridine (2,2'-Cyclouridine
- 2, 2'-Anhydro-Ur
- 2,2'-O-Cyclouridine >
- 2,2'-Anhydro-1(B-D-arabinofuranosyL
- 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, (2R,3R,3aS,9aR)-
- 2,2'-Cyclouridine USP/EP/BP
- 2,2'-Anhydro(1-β-D-arabinofuranosyl)uracil
- (2R,4R,5R,6S)-5-hydroxy-4-(hydroxymethyl)-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,?]dodeca-8,11-dien-10-one
- (2R,3R,3aS,9aR)-3-hydroxy-2-(hydroxymethyl)-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-6-one
- 2,2’-Anhydrouridine O-2,2’-Cyclouridine
- (2R,3R,3aS,9aR)-3-Hydroxy-2-(hydroxymethyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one
- 2,2'-Anhydro(β-D-arabinofuranosyl) uracil
- 2,2'-Anhydro-rU
- 2,2'-Anhydrouridine
- 2,2'-Anhydro-1(B-D-arabinofuranosyl)uracil
- 2,2 '- dehydrated uridine
- (2R,3R,3aS,9aR)-3-Hydroxy-2-(hydroxymethyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one , 2,2'-Anhydrouridine
- O2,2'-cyclouridine
- Ancitabine Impurity 2
- 2,2''-Anhydrouridine
- 3736-77-4
- C9H10N2O5
- Building Blocks
- Heterocyclic Building Blocks
- Pyrimidines
- Building Blocks
- C9 to C11
- Chemical Synthesis
- Heterocyclic Building Blocks